Driven by an extraordinary 54% surge in pharmaceutical exports to the United States—reaching €15.7 billion in 2025—Italy arrives at the BIO International Convention 2026 (San Diego, June 22-25) with an elite delegation of 20 companies, regional authorities, and research institutions.
Organised within the Italian National Pavilion by the Italian Trade Agency (ITA) in collaboration with the Ministry of Foreign Affairs, International Cooperation (MAECI), the Ministry of Enterprises and Made in Italy (MIMIT), and supported by Farmindustria, Federchimica Assobiotec, Invitalia, and Invest in Italy, the delegation represents a premier hub of global biotechnology.
